EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Pancreatogenic diabetes in immunoglobulin G4–related autoimmune pancreatitis managed with automated insulin delivery

Saraswathi Saiprasad iD, Theresa Cao, Narayana Swamy iD

JCEM Case Reports · 02.07.2026 · 4 (8)

DOI: 10.1210/jcemcr/luag174 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 13.07.2026. Verfasst von Saraswathi Saiprasad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology, Baylor Scott & White Health, Fort Worth, TX 76104, USA. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin G4 (IgG4)-related autoimmune pancreatitis (AIP) may mimic malignancy and lead to progressive pancreatic dysfunction. We describe a 75-year-old man with pancreatic mass lesions, biliary strictures, and elevated carbohydrate antigen 19-9 levels concerning for malignancy. Repeated pancreatic and biliary biopsies demonstrated chronic pancreatitis and fibrosis without carcinoma. Elevated IgG4 levels of 193.5 mg/dL (SI: 1.94 g/L; reference 4-86 mg/dL [SI: 0.04-0.86 g/L]) together with biopsy findings supported AIP. He developed severe exocrine and endocrine pancreatic dysfunction with worsening hyperglycemia and weight loss. Hemoglobin A1c (HbA1c) increased from 7% (SI: 53 mmol/mol) to >17% (SI: >163 mmol/mol; reference 3.8-5.6% [SI: 18-38 mmol/mol]). Autoimmune diabetes antibodies were negative. C-peptide declined over 6 weeks from 1.77 ng/mL (SI: 0.59 nmol/L) to 0.80 ng/mL (SI: 0.26 nmol/L) (reference 1.10-5.50 ng/mL [SI: 0.36-1.82 nmol/L]), supporting pancreatogenic diabetes. Automated insulin delivery achieved sustained glycemic improvement, with HbA1c improving to 7.6% (SI: 60 mmol/mol) at the most recent 18-month follow-up. This case highlights progressive endocrine failure and the utility of advanced diabetes technology in AIP-associated pancreatogenic diabetes.

Schlagwörter

Stichwörter der Autor:innen

IgG4-related autoimmune pancreatitisautomated insulin deliverycontinuous glucose monitoringexocrine pancreatic insufficiencypancreatogenic diabetes

Autor:innen und Institutionen

  • Endocrinology, Baylor Scott & White Health, Fort Worth, TX 76104, USA.
  • Internal Medicine Residency Program, Baylor Scott & White All Saints Medical Center, Fort Worth, TX 76104, USA.
  • Rheumatology, Baylor Scott & White Health, Fort Worth, TX 76104, USA.

ORCID-Profile: Saraswathi Saiprasad, Narayana Swamy

Zitieren

APA

Saiprasad, S., Cao, T., & Swamy, N. (2026). Pancreatogenic diabetes in immunoglobulin G4–related autoimmune pancreatitis managed with automated insulin delivery. JCEM Case Reports, 4(8). https://doi.org/10.1210/jcemcr/luag174

Vancouver

Saiprasad S, Cao T, Swamy N. Pancreatogenic diabetes in immunoglobulin G4–related autoimmune pancreatitis managed with automated insulin delivery. JCEM Case Reports. 2026;4(8). doi:10.1210/jcemcr/luag174

BibTeX
@article{Saiprasad2026,
  author = {Saiprasad, Saraswathi and Cao, Theresa and Swamy, Narayana},
  title = {Pancreatogenic diabetes in immunoglobulin G4–related autoimmune pancreatitis managed with automated insulin delivery},
  journal = {JCEM Case Reports},
  year = {2026},
  volume = {4},
  number = {8},
  doi = {10.1210/jcemcr/luag174}
}
Kostenlos starten →